MK-383 (Tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor

Author： Barlage Stefan   Wimmer Antonia   Pfeiffer Alexandra   Rothe Gregor   Schmitz Gerd  

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.13, Iss.3, 2002-05, pp. : 133-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bleeding Risk of Tirofiban, a Nonpeptide GPIIb/IIIa Platelet Receptor Antagonist in Progressive Stroke: An Open Pilot Study

By  

Cerebrovascular Diseases, Vol. 12, Iss. 4, 2001-11 ,pp. : 308-312

Karger

Access to resources Recommend Favorite

Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of treatment with platelet GPIIb/IIIa receptor blockade in unstable angina patients awaiting PTCA at a referring clinic

By Umans Victor A   Cornel Jan H   Velthoven Stella Schrijver-van   Kloeg Paul   Bartels Piet   Bronzwaer Jean  

International Journal of Cardiovascular Interventions, Vol. 2, Iss. 4, 1999-01 ,pp. : 223-230

Informa Healthcare

Access to resources Recommend Favorite

Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic arg-gly-asp peptide

By Tsao P.W.   Bozarth J.M.   Jackson S.A.   Forsythe M.S.   Flint S.K.   Mousa S.A.  

Thrombosis Research, Vol. 77, Iss. 6, 1995-03 ,pp. : 543-556

Elsevier

Access to resources Recommend Favorite